Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
90 percent bed ridden; unable to walk; unable to function; balance issues; Guillain-Barre syndrome; This serious case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced guillain barre syndrome (Verbatim: Guillain-Barre syndrome) (serious criteria GSK medically significant and other: Serious as per reporter), bedridden (Verbatim: 90 percent bed ridden), unable to walk (Verbatim: unable to walk), performance status decreased (Verbatim: unable to function) and balance difficulty (Verbatim: balance issues). The outcome of the guillain barre syndrome was unknown (duration 2 days) and the outcome of the bedridden, unable to walk, performance status decreased and balance difficulty were not reported. The reporter considered the guillain barre syndrome to be related to Shingrix. It was unknown if the reporter considered the bedridden, unable to walk, performance status decreased and balance difficulty to be related to Shingrix. The company considered the guillain barre syndrome to be unrelated to Shingrix. It was unknown if the company considered the bedridden, unable to walk, performance status decreased and balance difficulty to be related to Shingrix. Additional Information: GSK Receipt Date : 09-MAR-2025 This case was reported by a patient via interactive digital media. Patient developed Guillain-Barre syndrome (GBS) after receiving the first shingles shot. As a result, she was 90 percent bedridden, unable to walk or function. She had to re-learn to walk, dealing with balance issues, and it was a long three year journey. Her physician had recommended the vaccine after she recovered from shingles to prevent a recurrence, but the vaccination was worse and caused nerve damage. she should have never taken the shot.; Sender's Comments: Guillain-Barre syndrome is an unlisted event which is considered unrelated to GSK vaccine Shingrix
Medical History/Concurrent Conditions: Shingles